The United States government, as soon as it learned about the relative effectiveness of Remdesivir for reducing Covid-19 symptoms and the effect it has on accelerating the recovery of patients, bought the pharmaceutical Gilead, which manufactures it exclusively, practically all the stock available for the next three months.
In the middle of last March, several German government officials commented, with indignation, a news that guaranteed that the American government offered one billion dollars to the German pharmaceutical company CureVac, to give the vaccine exclusive to Covid19, which is about to be tested.
